Annual Non Current Assets
$21.61 M
+$4.36 M+25.26%
December 31, 2024
Summary
- As of March 8, 2025, RNA annual long term assets is $21.61 million, with the most recent change of +$4.36 million (+25.26%) on December 31, 2024.
- During the last 3 years, RNA annual non current assets has risen by +$5.17 million (+31.43%).
- RNA annual non current assets is now at all-time high.
Performance
RNA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$21.61 M
+$2.70 M+14.28%
December 31, 2024
Summary
- As of March 8, 2025, RNA quarterly long term assets is $21.61 million, with the most recent change of +$2.70 million (+14.28%) on December 31, 2024.
- Over the past year, RNA quarterly non current assets has increased by +$2.70 million (+14.28%).
- RNA quarterly non current assets is now at all-time high.
Performance
RNA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RNA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.3% | +14.3% |
| 3 y3 years | +31.4% | +14.3% |
| 5 y5 years | +1655.1% | +14.3% |
RNA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.2% | at high | +36.2% |
| 5 y | 5-year | at high | +1655.1% | at high | +1655.1% |
| alltime | all time | at high | +2819.6% | at high | +1655.1% |
Avidity Biosciences Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.54 B(+152.3%) | $21.61 M(+14.3%) |
| Sep 2024 | - | $18.91 M(+1.5%) |
| Jun 2024 | - | $18.62 M(+9.6%) |
| Mar 2024 | - | $17.00 M(-1.4%) |
| Dec 2023 | $611.31 M(-1.9%) | $17.25 M(-2.4%) |
| Sep 2023 | - | $17.68 M(+8.8%) |
| Jun 2023 | - | $16.25 M(-3.4%) |
| Mar 2023 | - | $16.83 M(+6.1%) |
| Dec 2022 | $622.94 M | $15.86 M(-1.3%) |
| Sep 2022 | - | $16.07 M(-2.9%) |
| Jun 2022 | - | $16.55 M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $16.34 M(-0.6%) |
| Dec 2021 | $411.14 M(+24.0%) | $16.44 M(+315.2%) |
| Sep 2021 | - | $3.96 M(+23.2%) |
| Jun 2021 | - | $3.21 M(+14.7%) |
| Mar 2021 | - | $2.80 M(+26.2%) |
| Dec 2020 | $331.68 M(+246.7%) | $2.22 M(+20.9%) |
| Sep 2020 | - | $1.84 M(+19.4%) |
| Jun 2020 | - | $1.54 M(-36.5%) |
| Mar 2020 | - | $2.42 M(+96.7%) |
| Dec 2019 | $95.68 M(+2851.1%) | $1.23 M |
| Dec 2018 | $3.24 M | - |
FAQ
- What is Avidity Biosciences annual long term assets?
- What is the all time high annual non current assets for Avidity Biosciences?
- What is Avidity Biosciences annual non current assets year-on-year change?
- What is Avidity Biosciences quarterly long term assets?
- What is the all time high quarterly non current assets for Avidity Biosciences?
- What is Avidity Biosciences quarterly non current assets year-on-year change?
What is Avidity Biosciences annual long term assets?
The current annual non current assets of RNA is $21.61 M
What is the all time high annual non current assets for Avidity Biosciences?
Avidity Biosciences all-time high annual long term assets is $21.61 M
What is Avidity Biosciences annual non current assets year-on-year change?
Over the past year, RNA annual long term assets has changed by +$4.36 M (+25.26%)
What is Avidity Biosciences quarterly long term assets?
The current quarterly non current assets of RNA is $21.61 M
What is the all time high quarterly non current assets for Avidity Biosciences?
Avidity Biosciences all-time high quarterly long term assets is $21.61 M
What is Avidity Biosciences quarterly non current assets year-on-year change?
Over the past year, RNA quarterly long term assets has changed by +$2.70 M (+14.28%)